ArticleNeurodegenerative disease management2013
Current guidelines for dementia screening: shortcomings and recommended changes.
Article in Neurodegenerative disease management, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Article
- Narrative Review of Sensory Changes as a Biomarker for Alzheimer's Disease.Biological research for nursing · 2021Review
- Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia.Journal of Alzheimer's disease : JAD · 2021Article
- Article
- Editorial: Screening for Mild Cognitive Impairment: There Is the Will but Is There a Way?The journal of prevention of Alzheimer's disease · 2020Article
- Intention to Be Screened for Alzheimer's Disease in Nondemented Older Adults: Integrated Behavioral Model and Self-Efficacy as Mediation Effect.Journal Of Human Behavior In The Social Environment · 2020Article
- Physician Practice Patterns Associated with Diagnostic Evaluation of Patients with Suspected Mild Cognitive Impairment and Alzheimer's Disease.International journal of Alzheimer's disease · 2019Article
- Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia.Current geriatrics reports · 2018Article
- A Method to Differentiate Mild Cognitive Impairment and Alzheimer in MR Images using Eigen Value Descriptors.Journal of medical systems · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The availability of various guidelines regarding the diagnosis of Alzheimer's disease (AD) leaves most primary care providers with the task of having to decide which guidelines to follow. This review will help them navigate these different guidelines and understand how they differ from previous guidelines. Challenges related to the use of these guidelines are discussed, including biomarker testing, the lack of recognition in the community of what constitutes memory impairment and how to best screen for it, and recommendations for easy and early detection and diagnosis in the clinical settings are made. Adoption of biomarkers in clinical practice will give primary care providers the means to establish with certainty the underlying pathology responsible for the observed clinical symptoms and increase their ability to establish the presence of AD pathology before symptoms occur and, therefore, potentially help prevent or slow down the progression to AD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.